STOCK TITAN

Henry Schein (HSIC) Stock News

HSIC NASDAQ

Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.

Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.

Rhea-AI Summary

Henry Schein (HSIC) will exclude acquisition-related remeasurement gains from its non-GAAP financial results beginning with fourth-quarter 2026 reporting.

The change removes gains recognized when previously held minority investments become controlling interests. FY2026 non-GAAP diluted EPS guidance falls to $5.42–$5.48 from $5.50–$5.56, solely reflecting the exclusion of $0.08 in first-quarter gains. Total sales growth guidance remains 4.5%–5.5%, and adjusted EBITDA growth guidance remains high-single-digits; the underlying business outlook is unchanged.

Historical figures were recast for 2024, 2025 and the first nine months of 2026. Recast non-GAAP diluted EPS is $4.58, $4.65 and $4.06, respectively. The change does not affect GAAP results. Henry Schein believes excluding these gains better reflects underlying performance and improves comparisons across periods.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
none
-
Rhea-AI Summary

Henry Schein (HSIC) and CareQuest Institute for Oral Health launched the BRIDGE Health Network to pilot health screenings during routine dental hygiene visits. Initial pilots will include patient vitals, lifestyle markers and point-of-care screening, including HbA1c, a blood sugar measure.

Henry Schein will lead pilot implementation and handle device and supply distribution, technical support, clinic engagement and training. CareQuest will provide program-level data in partnership with Henry Schein and participating clinics. Dentrix Ascend has added fields to capture screening data in dental records. The inaugural cohort includes community providers, dental organizations and academic institutions. The collaborators aim to assess screening feasibility and outcomes and develop a playbook for dental-medical integration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) will present at investor conferences in London on November 17 and New York on December 1, 2026. The Jefferies Healthcare Conference presentation starts at 9:00 a.m. Greenwich Time/4:00 a.m. Eastern time; the Piper Sandler Healthcare Conference presentation starts at 9:00 a.m. Eastern time. Both presentations will have live webcasts, with replays available afterward on the company website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
conferences
Rhea-AI Summary

Henry Schein (HSIC) raised its full-year earnings outlook after reporting third-quarter GAAP diluted earnings of $1.06 per share, up 26.2% year over year. For the quarter ended September 26, 2026, sales rose 4.0% to $3.471 billion, including 3.1% internal growth in local currencies. Non-GAAP diluted EPS increased 13.0% to $1.56, including a $0.19 net tariff-refund benefit. Adjusted EBITDA, an adjusted earnings measure, reached $321 million versus $295 million; its margin expanded 40 basis points to 9.24%.

The company raised 2026 non-GAAP diluted EPS guidance to $5.50–$5.56 from $5.29–$5.39 and now expects high-single-digit adjusted EBITDA growth. Sales growth guidance remains 4.5%–5.5%. U.S. dental merchandise sales grew 8.6%, while global value-added services sales fell 4.8%. Operating cash flow declined to $161 million from $174 million a year earlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.76%
Tags
none
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) will release its third quarter 2026 financial results before the market opens on November 3, 2026. Its earnings conference call will be webcast live at 8:00 a.m. Eastern time that day through the investor website, with a replay available afterward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
conferences
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) named Emmanuel Caprais as Senior Vice President and Chief Financial Officer, effective November 4, 2026. Caprais will begin as Senior Financial Advisor on October 12, 2026, to support the transition. He will join the Henry Schein Leadership Team and report to CEO Frederick M. Lowery.

Current CFO Ronald N. South will move into a senior advisory role on November 4, 2026, after 18 years with the company. Caprais served as ITT’s CFO from 2020 until May 2026. Henry Schein also anticipates adding a Chief Strategy and Transformation Officer and a technology leadership position covering AI implementation, data and broader technology needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
management
Rhea-AI Summary

Henry Schein (HSIC) is marking 25 years of Henry Schein Cares, its global corporate citizenship program launched in 2001. Since its launch, the program has contributed more than $285 million in cash and donated products and collaborated with more than 5,000 charitable partners worldwide. It has delivered over 100,000 hygiene kits through the We Care Global Challenge and supported more than 75,000 students through its Back to School program.

A September 23 anniversary event in New York City previewed future priorities, including access to care, dental-medical integration and disaster preparedness. Henry Schein is targeting 100% renewable energy by 2030, currently achieving 34% through renewable energy certificates. It is also partnering with Climeworks Solutions to invest in its first carbon removal portfolio as part of efforts toward its Net Zero 2050 goal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary

Henry Schein (HSIC) will present at the Baird Global Healthcare Conference at the InterContinental Hotel in New York City on September 15, 2026, at 12:15 p.m. EDT.

The presentation can be accessed via live webcast at the company’s investor relations webcast page, with replays available on Henry Schein’s website after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
conferences
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) reported Q2 2026 net sales of $3.46 billion, up 6.7% year over year, driven by 4.6% internal growth, 0.7% from acquisitions, and 1.4% from foreign exchange. GAAP diluted EPS rose to $0.82 from $0.70, and non-GAAP diluted EPS increased to $1.27 from $1.10. Adjusted EBITDA reached $288 million versus $256 million a year ago.

For the first half of 2026, sales grew 6.5% to $6.83 billion and GAAP diluted EPS rose to $1.74. Henry Schein raised 2026 guidance to non-GAAP diluted EPS of $5.29–$5.39, total sales growth of 4.5%–5.5%, and mid- to high-single-digit Adjusted EBITDA growth. The company repurchased $200 million of stock in Q2 and $325 million year-to-date, with $455 million remaining authorized.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) announced a major leadership reorganization, creating the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee and integrating its global supply chain organization with its global distribution group.

The new structure is intended to support strategic priorities, faster decision-making, and a more customer-centric operating model. Effective October 30, 2026, Executive Vice President & COO Michael S. Ettinger, Executive Vice President & Chief Strategy Officer Mark E. Mlotek, and Senior Vice President, Global Supply Chain James (“Jim”) Mullins will transition out of their current roles and, from October 31, 2026, continue as Senior Advisors to the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
management

FAQ

What is the current stock price of Henry Schein (HSIC)?

Henry Schein (HSIC) last closed at $83.52.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately $9.2B.